Left Ventricular Assist Device Market Key developments and strategies observed in the market


Sanketphadtare535

Uploaded on Jan 4, 2023

A significant increase in the prevalence of target diseases and a rise in the global geriatric population drive the market growth. However, a surge in product recalls and complications associated with left ventricular assist devices hamper the market growth. for more.. https://www.theinsightpartners.com/reports/left-ventricular-assist-device-market

Comments

                     

Left Ventricular Assist Device Market Key developments and strategies observed in the market

Left Ventricular Assist Device Market Global Analysis and Forecast to 2028 Published Date : Oct 2022 Email: [email protected] Email: [email protected] Report Studies  Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Flow (Pulsatile and Non-Pulsatile), Design (Implantable Ventricular Assist Devices and Transcutaneous Ventricular Assist Devices), and Application (Bridge-to-Transplantation, Destination Therapy, Bridge-to-Recovery, and Bridge-to-Candidacy) 2 Email: [email protected] Left Ventricular $50,000 Assist Device Market Value $40,000 $30,000 CAGR of 5.1% $20,000 (2022 - 2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX 3 Email: [email protected] Left Ventricular Assist Device Market Overview  The left ventricular assist device market is expected to reach US$ 1,806.19 million by 2028 & registering at a CAGR of 5.1% from 2022 to 2028, according to a new research study conducted by The Insight Partners.  A significant increase in the prevalence of target diseases and a rise in the global geriatric population drive the market growth. However, a surge in product recalls and complications associated with left ventricular assist devices hamper the market growth. 4 Email: [email protected] Key Segment Market Segment By Type:-  By Type of Flow (Pulsatile and Non-Pulsatile)  By Design (Implantable Ventricular Assist Devices and Transcutaneous Ventricular Assist Devices)  By Application (Bridge-to-Transplantation, Destination Therapy, Bridge-to-Recovery, and Bridge-to-Candidacy) 5 Email: [email protected] Company Profiles  ABIOMED Inc  Abbott Laboratories  Medtronic Plc  LivaNova Plc  Jarvik Heart Inc  Terumo Corp  Berlin Heart GmbH  BiVACOR Inc  Evaheart Inc  BioVentrix Inc 6 Download Sample Her e Email: [email protected] By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7 THANK YOU! Phone : +1-646-491-9876 E-Mail : [email protected]